Career history of Anette Sundstedt
Former positions of Anette Sundstedt
Companies | Position | Start | End |
---|---|---|---|
ALLIGATOR BIOSCIENCE AB | Director/Board Member | 2023-07-04 | 2024-05-06 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Corporate Officer/Principal | 2020-03-31 | 2021-02-28 |
ACTIVE BIOTECH AB | Director/Board Member | 2000-12-31 | 2015-12-31 |
IDOGEN AB (PUBL) | Chief Tech/Sci/R&D Officer | - | - |
Training of Anette Sundstedt
University of Lund | Doctorate Degree |
Statistics
International
Sweden | 6 |
Operational
Director/Board Member | 2 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ACTIVE BIOTECH AB | Health Technology |
IDOGEN AB (PUBL) | Health Technology |
ALLIGATOR BIOSCIENCE AB | Health Technology |
Private companies | 1 |
---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Stock Market
- Insiders
- Anette Sundstedt
- Experience